PARP is activated in human asthma and its inhibition by olaparib blocks house dust mite-induced disease in mice

Our laboratory established a role for poly(ADP-ribose)polymerase (PARP) in asthma. To increase the clinical significance of our studies, it is imperative to demonstrate that PARP is actually activated in human asthma, to examine whether a PARP inhibitor approved for human testing such as olaparib bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghonim, Mohamed A., Pyakurel, Kusma, Ibba, Salome V., Wang, Jeffrey, Rodriguez, Paulo, Al-Khami, Amir A., Lammi, Matthew R., Kim, Hogyoung, Zea, Arnold H., Davis, Christian, Okpechi, Samuel, Wyczechowska, Dorota, Al-Ghareeb, Kamel, Mansy, Moselhy S., Ochoa, Augusto, Naura, Amarjit S., Boulares, A. Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2015
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613510/
https://www.ncbi.nlm.nih.gov/pubmed/26205779
http://dx.doi.org/10.1042/CS20150122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613510/
https://www.ncbi.nlm.nih.gov/pubmed/26205779
http://dx.doi.org/10.1042/CS20150122

Ejemplares similares